Market comparison
When will the FDA approve Intellia Therapeutics' lonvo-z?
1 venue · 3 outcome rows · 0 comparable lines · 0 verified parity · active
Kalshi
Open venue ↗3 outcomes · $7K reported volume
Observed 2m ago
Recorded venue end date: Jan 1, 2028
No shared outcome identities or comparable outcome lines are available for this event. Each venue’s outcomes are listed separately.
| Outcome | Kalshi | Difference |
|---|---|---|
Before 2028 Not alignedNo persisted outcome identity connects these venue contracts. | — | |
Before July 2027 Not alignedNo persisted outcome identity connects these venue contracts. | — | |
Before October 2027 Not alignedNo persisted outcome identity connects these venue contracts. | — |
Before 2028
Not alignedNo persisted outcome identity connects these venue contracts.
Kalshi
Before July 2027
Not alignedNo persisted outcome identity connects these venue contracts.
Kalshi
Before October 2027
Not alignedNo persisted outcome identity connects these venue contracts.
Kalshi
Prices are shown as percentages of a $1 payout. “pp” means percentage points. A dash means data is unavailable.